All News

The FDA has granted fast track designations to cavrotolimod (AST-008) for use in combination with a PD-1 therapy in patients with locally advanced or metastatic Merkel cell carcinoma.

Amneal Pharmaceuticals, Inc announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application from the FDA for Abiraterone Acetate tablets.

Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.

Pvsripo is a novel immunotherapy that activates patients’ innate and adaptive immune system to enable anti-tumor response and establish immunologic memory to prevent the recurrence of cancer.

With approximately 328 million people currently living in the United States, it will take an army of health care professionals to vaccinate the country against COVID-19.

A pilot study published today in Addiction found that a collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction.

New research suggests immunosuppressants do not increase the risk of COVID-19.

Annual awards program recognizes pharmacists, technicians, students and industry advocates who are defining the future of pharmacy.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

When examining the percentage of posts that made the vaccine seem more dangerous, less dangerous, or neither, Luisi found nearly 40% of Facebook posts about the HPV vaccine amplified a perceived risk.

In patients with severe cardiac failure, the extreme emaciation of the body is a potential result and has been termed cardiac cachexia.

A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.

Darolutamide led to a 31% reduction in the risk of death, extending survival for patients with non-metastatic prostate cancer.

The online guide places a special emphasis on security, storage, and handling.

In the past week, Moderna and AstraZeneca have collectively announced multiple authorizations for use of their respective vaccines.

Despite the concerns that may come along with mutations of the SARS-CoV-2 virus, experts say the new strains do not call for any new prevention strategies.

In a recent study at the National Institutes of Health, researchers consistently observed signs of damage on the brain scans of patients who died after contracting COVID-19.

Pralatrexate, a lymphoma drug, outperformed remdesivir in treating COVID-19 in a lab experiment.

The first article in this 3-part series covered a general overview of the survey and its respondents. In this article, we will explore the questions and answers around compensation.

According to the study authors, this could lead to finding the exact molecular trigger and gives hope for developing a targeted PsA treatment in the future.